Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Predictive Infection Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae

NCT07396571 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.

NCT NCT07396571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07396571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Predictive Infection Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase
Observational
Overall status
Not yet recruiting
Start date
September 4, 2026
Completion date
December 31, 2028
Enrollment
535 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

colonization, enterobacteria non susceptible to carbapenem carrier, esbl-producing enterobacteriaceae infections, hemato-oncologic patients, neutropenia